Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Dr. Reddy's Laboratories Ltd (RDY)

32.14 -0.27 (-0.83%)

04-20 16:02

Open:

32.34

Pre. Close:

32.41

High:

32.35

Low:

32.09

Volume:

128,867

Market Cap:

5288M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

32.419 - 32.614

32.614 - 32.759

Low:

31.618 - 31.88

31.88 - 32.075

Close:

31.798 - 32.182

32.182 - 32.468

Technical analysis  (as of: 2018-04-20 4:33:06 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 38.52     One year: 39.36

Support:

Support1: 31.82    Support2: 26.47

Resistance:

Resistance1: 32.98    Resistance2: 33.70

Pivot:

32.57

Moving Averages:

MA(5): 32.40     MA(20): 32.55

MA(100): 34.86     MA(250): 36.43

MACD:

MACD(12,26): -0.29     Signal(12,26,9): -0.31

%K %D:

%K(14,3): 33.33     %D(3): 39.14

RSI:

RSI(14): 39.19

52-Week:

High: 42.97  Low: 29.83  Change(%): -21.4

Average Vol(K):

3-Month: 31287  10-Days 26728

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
RDY has closed above bottom band by 8.3%. Bollinger Bands are 67.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to RDY's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-02T07:31:44-04:00
Dr. Reddy's Lab and Promius Pharma files NDA for its migraine candidate

2018-04-02T04:19:00-04:00
Dr. Reddy's Laboratories and its U.S. subsidiary Promius Pharma announce the filing of an NDA for its migraine candidate

2018-03-29T06:43:23-04:00
Dr. Reddy's Lab announces senior leadership changes

2018-03-29T01:45:00-04:00
Dr. Reddy's Laboratories Announces Senior Leadership Changes

2018-03-26T01:34:00-04:00
Dr. Reddy's Laboratories Announces the Launch of Palonosetron Hydrochloride Injection in the U.S. Market

2018-03-16T07:39:14-04:00
Dr. Reddy's Laboratories launches Levocetirizine Dihydrochloride Tablets USP, 5 mg in the U.S. market

2018-03-16T03:42:00-04:00
Dr. Reddy's Laboratories Announces the Launch of Levocetirizine Dihydrochloride Tablets USP, 5 mg in the U.S. Market

2018-02-19T10:35:15-05:00
Warren Buffett's Berkshire Claims $358 Million Investment In Teva, But That Doesn't Change The Final Outcome

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

165.89

Shares Float (M)

165.89

% Held by Insiders

% Held by Institutions

41.00

Shares Short (K)

2385

Shares Short Prior Month (K)

2810

Stock Financials

EPS

1.040

EPS Est. Current Year

1.200

EPS Est. Next Year

1.810

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

2.830

PEG Ratio

Profit Margin

6.36

Operating Margin

9.34

Return on Assets (ttm)

4.5

Return on Equity (ttm)

8.4

Qtrly Rev. Growth

3.4

Gross Profit (p.s.)

5.361

Sales Per Share

EBITDA (p.s.)

1.861

Qtrly Earnings Growth

-28.90

Operating Cash Flow (M)

319.78

Levered Free Cash Flow (M)

69.03

atoplab.com

Valuation

P/E

30.90

P/E Growth Ratio

-0.01

P/BV

11.36

P/S

404690656.00

P/CF

16.67

Dividend Yield

0.03

Dividends & Splits

Dividend

0.909

Dividend Pay Date

2017-08-10

Ex-Dividend Date

2017-07-13

Forward Dividend

0.310

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.